Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-45513

ABSTRACT: Mouse Spontaneous C3H/HeJ AA Skin

OTHER RELATED OMICS DATASETS IN: PRJNA252923PRJNA194537PRJNA194564PRJNA194534PRJNA194536PRJNA195564

PROVIDER: E-GEOD-45513 | ExpressionAtlas | 2015-07-11

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-45513-analysis-methods.tsv	Tabular
	E-GEOD-45513-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-45513-configuration.xml	Xml
	E-GEOD-45513-percentile-ranks.tsv	Tabular
	E-GEOD-45513.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 53

Similar Datasets

Mus musculus

Project description:Mouse Spontaneous C3H/HeJ AA Skin

| PRJNA194537 | ENA

Mouse Spontaneous C3H/HeJ AA Skin

2014-08-17 | GSE45513 | GEO

Mouse Spontaneous C3H/HeJ AA Skin

Project description:Our goal was to develop a transcriptomic description of affected alopecic skin from aged C3H/HeJ mice. Affected skin from 3 mice was compared to skin from similarly aged but unaffected C3H/HeJ mice. 3 biological replicates from 3 separate affected mice compared with 3 biological replicate controls from 3 unaffected mice

2014-08-17 | E-GEOD-45513 | biostudies-arrayexpress

miRNA profiling of C3H/HeJ mice with and without spontaneous alopecia areata

Project description:Our goal was to identify miRNA expression patterns that correlated with spontaneous onset of autoimmune alopecia in C3H/HeJ mice compare to normal haired controls. Skin from 3 mice with or without spontaneous AA were taken for the study.

2017-02-03 | GSE94407 | GEO

Treatment of C3H/HeJ grafted mice with baricitinib [topical]

Project description:The C3H/HeJ grafted model of alopecia areata was used to determine the efficacy of systemic baricitinib at preventing alopecia or treating established disease. The efficacy of topical baricitinib at treating established alopecia in the C3H/HeJ grafted model was also assessed. Microarrays were performed on skin RNA at week 0 and week 12 after starting treatment in all models.

2015-05-01 | GSE61554 | GEO

Treatment of C3H/HeJ grafted mice with baricitinib [systemic]

2015-05-01 | GSE61552 | GEO

Treatment of C3H/HeJ grafted mice with baricitinib [prevention]

2015-05-01 | GSE61551 | GEO

Treatment of C3H/HeJ grafted mice with baricitinib [prevention]

2015-05-01 | E-GEOD-61551 | biostudies-arrayexpress

Treatment of C3H/HeJ grafted mice with baricitinib [systemic]

2015-05-01 | E-GEOD-61552 | biostudies-arrayexpress

Treatment of C3H/HeJ grafted mice with baricitinib [topical]

2015-05-01 | E-GEOD-61554 | biostudies-arrayexpress